ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 17.59 USD -1.9% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
ACADIA Pharmaceuticals Inc?
Write Note

Net Margin
ACADIA Pharmaceuticals Inc

13.8%
Current
-24%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.8%
=
Net Income
128.5m
/
Revenue
929.2m

Net Margin Across Competitors

Country US
Market Cap 2.9B USD
Net Margin
14%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 301B USD
Net Margin
9%
Country US
Market Cap 162B USD
Net Margin
13%
Country US
Market Cap 127.5B USD
Net Margin
-5%
Country US
Market Cap 115.4B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 138B AUD
Net Margin
18%
Country US
Market Cap 88.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for ACADIA Pharmaceuticals Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.8%
=
Net Income
128.5m
/
Revenue
929.2m
What is the Net Margin of ACADIA Pharmaceuticals Inc?

Based on ACADIA Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of 13.8%.